The role of SARS‐CoV‐2 antibodies in COVID‐19: Healing in most, harm at times

Saved in:
Bibliographic Details
Published inRespirology (Carlton, Vic.) Vol. 25; no. 7; pp. 680 - 682
Main Authors French, Martyn A., Moodley, Yuben
Format Journal Article
LanguageEnglish
Published Chichester, UK John Wiley & Sons, Ltd 01.07.2020
Wiley Subscription Services, Inc
Subjects
antibodies
Antibody Formation
Betacoronavirus
Commentaries
Coronavirus
Coronavirus Infections
COVID-19
Humans
immunopathology
Pandemics
Pneumonia, Viral
Respiratory diseases
SARS Virus
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
COVID-19
antibodies
immunopathology
Online AccessGet full text

Cover

Author French, Martyn A.
Moodley, Yuben
AuthorAffiliation 3 Medical School University of Western Australia Perth WA Australia
4 Department of Respiratory Medicine Fiona Stanley Hospital Perth WA Australia
2 Division of Immunology PathWest Laboratory Medicine Perth WA Australia
5 Institute of Respiratory Health Perth WA Australia
1 School of Biomedical Sciences University of Western Australia Perth WA Australia
AuthorAffiliation_xml – name: 3 Medical School University of Western Australia Perth WA Australia
– name: 4 Department of Respiratory Medicine Fiona Stanley Hospital Perth WA Australia
– name: 5 Institute of Respiratory Health Perth WA Australia
– name: 2 Division of Immunology PathWest Laboratory Medicine Perth WA Australia
– name: 1 School of Biomedical Sciences University of Western Australia Perth WA Australia
Author_xml – sequence: 1
  givenname: Martyn A.
  orcidid: 0000-0002-4644-1982
  surname: French
  fullname: French, Martyn A.
  organization: PathWest Laboratory Medicine
– sequence: 2
  givenname: Yuben
  orcidid: 0000-0002-0777-1196
  surname: Moodley
  fullname: Moodley, Yuben
  organization: Institute of Respiratory Health
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32436320$$D View this record in MEDLINE/PubMed
BookMark eNp9kc1OGzEQx62KqkDohQdAlrhUFQv-3A8OlaIQGiQkKgJcLa8zS4x27WBvirj1EfqMPAkOAdT20Dl4xuOf_hrPfxttOO8AoV1KDmmKowBxcUh5KdkHtEWFIBktBd9INWc8K4qq2kTbMd4RQrgk8hPa5EzwnDOyhaZXc8DBt4B9g6fDy-nTr98jf5NOhrXrbe1nFiK2Do8ubs5OUp9Wx3gCurXudtXufOwP8FyHDuse97aDuIM-NrqN8Pk1D9D16fhqNMnOL76fjYbnmZFUsKzhRdHks0pLI82s4XnJdMPKus5FaRjXBpjMQUrDZV6K3CS-qgsBtMxNIdN1gL6tdRfLuoOZAdcH3apFsJ0Oj8prq_5-cXaubv1PVbCSFJwmgS-vAsHfLyH2qrPRQNtqB34ZFRNEck5p2tYA7f-D3vllcOl7iaKCpiVzkqiva8oEH2OA5n0YStTKK7XySr14leC9P8d_R9_MSQBdAw-2hcf_SKnL8fTHWvQZhiqhOA
CitedBy_id crossref_primary_10_1063_5_0031521
crossref_primary_10_1371_journal_pone_0246864
crossref_primary_10_1111_sji_12972
crossref_primary_10_1186_s12884_021_03985_1
crossref_primary_10_3389_fimmu_2022_856033
crossref_primary_10_1097_TP_0000000000003524
crossref_primary_10_1002_jmv_26899
crossref_primary_10_3389_fimmu_2022_989556
crossref_primary_10_1007_s11357_024_01215_y
crossref_primary_10_3390_vaccines10122063
crossref_primary_10_3390_math9243274
crossref_primary_10_1371_journal_pone_0283537
crossref_primary_10_4103_ijmr_IJMR_3564_20
crossref_primary_10_1038_s44172_024_00185_5
crossref_primary_10_1002_jmv_26863
crossref_primary_10_1002_jmv_27291
crossref_primary_10_1007_s00216_021_03377_6
crossref_primary_10_1016_j_pathol_2020_09_007
crossref_primary_10_1016_j_jare_2020_12_013
crossref_primary_10_1128_mBio_00765_21
crossref_primary_10_22141_2312_413X_9_1_2021_228823
Cites_doi 10.1016/j.cellimm.2018.07.009
10.1016/j.bbrc.2014.07.090
10.1021/acsinfecdis.6b00006
10.1111/acel.13087
10.3389/fimmu.2017.00780
10.1007/s00281-017-0629-x
10.1371/journal.pntd.0002274
10.1038/s41586-020-2196-x
10.1101/2020.03.30.20047365
10.1371/journal.pone.0035421
10.1093/cid/ciaa489
10.1128/JVI.00671-11
10.1172/jci.insight.123158
10.1126/science.aai8128
10.1016/S1473-3099(20)30196-1
10.1093/cid/ciaa34
10.1093/cid/ciaa310
10.1016/j.chom.2020.04.009
ContentType Journal Article
Copyright 2020 Asian Pacific Society of Respirology
Copyright_xml – notice: 2020 Asian Pacific Society of Respirology
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7T5
H94
7X8
5PM
DOI 10.1111/resp.13852
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Immunology Abstracts
AIDS and Cancer Research Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
AIDS and Cancer Research Abstracts
Immunology Abstracts
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate The role of SARS‐CoV‐2 antibodies in COVID‐19
EISSN 1440-1843
EndPage 682
ExternalDocumentID 10_1111_resp_13852
32436320
RESP13852
Genre reviewArticle
Comment
Journal Article
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
10A
123
1OB
1OC
29P
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5HH
5LA
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABEML
ABJNI
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFZJQ
AHBTC
AHEFC
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
AOETA
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EBS
EJD
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
FZ0
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
KBYEO
KMS
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
TEORI
UB1
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOQ
WOW
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
XG1
YFH
ZZTAW
~IA
~WT
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7T5
H94
7X8
5PM
ID FETCH-LOGICAL-c5142-f377f6d9a5c5cdf3682af28bb648c23ace256e55c356846cf379b74e186c75cf3
IEDL.DBID DR2
ISSN 1323-7799
IngestDate Tue Sep 17 21:16:15 EDT 2024
Fri Aug 16 12:12:32 EDT 2024
Thu Oct 10 22:48:18 EDT 2024
Fri Aug 23 04:36:45 EDT 2024
Sat Sep 28 08:29:48 EDT 2024
Sat Aug 24 01:06:37 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords COVID-19
antibodies
immunopathology
Language English
License This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5142-f377f6d9a5c5cdf3682af28bb648c23ace256e55c356846cf379b74e186c75cf3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Commentary-3
content type line 23
ORCID 0000-0002-4644-1982
0000-0002-0777-1196
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC7280731
PMID 32436320
PQID 2414179930
PQPubID 2045110
PageCount 3
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_7280731
proquest_miscellaneous_2405331124
proquest_journals_2414179930
crossref_primary_10_1111_resp_13852
pubmed_primary_32436320
wiley_primary_10_1111_resp_13852_RESP13852
PublicationCentury 2000
PublicationDate July 2020
PublicationDateYYYYMMDD 2020-07-01
PublicationDate_xml – month: 07
  year: 2020
  text: July 2020
PublicationDecade 2020
PublicationPlace Chichester, UK
PublicationPlace_xml – name: Chichester, UK
– name: Australia
– name: Richmond
PublicationTitle Respirology (Carlton, Vic.)
PublicationTitleAlternate Respirology
PublicationYear 2020
Publisher John Wiley & Sons, Ltd
Wiley Subscription Services, Inc
Publisher_xml – name: John Wiley & Sons, Ltd
– name: Wiley Subscription Services, Inc
References 2017; 8
2019; 4
2016; 2
2020; 20
2017; 39
2020
2018; 333
2020; 27
2011; 85
2014; 451
2013; 7
2012; 7
2017; 355
2020; 19
32337590 - Clin Infect Dis. 2020 Apr 27;:null
32221519 - Clin Infect Dis. 2020 Mar 28;:null
e_1_2_2_4_1
e_1_2_2_14_1
e_1_2_2_5_1
e_1_2_2_13_1
e_1_2_2_6_1
e_1_2_2_12_1
e_1_2_2_7_1
e_1_2_2_11_1
e_1_2_2_10_1
e_1_2_2_2_1
e_1_2_2_3_1
e_1_2_2_19_1
e_1_2_2_9_1
e_1_2_2_18_1
e_1_2_2_8_1
e_1_2_2_17_1
e_1_2_2_16_1
e_1_2_2_15_1
References_xml – volume: 2
  start-page: 361
  year: 2016
  end-page: 76
  article-title: Immunodominant SARS coronavirus epitopes in humans elicited both enhancing and neutralizing effects on infection in non‐human primates (Published correction appears in . 2020)
  publication-title: ACS Infect. Dis.
– volume: 7
  year: 2013
  article-title: Correlation between dengue‐specific neutralizing antibodies and serum avidity in primary and secondary dengue virus 3 natural infections in humans
  publication-title: PLoS Negl. Trop. Dis.
– year: 2020
  article-title: Virological assessment of hospitalized patients with COVID‐2019
  publication-title: Nature
– volume: 27
  start-page: 1
  year: 2020
  end-page: 9
  article-title: Complex immune dysregulation in COVID‐19 patients with severe respiratory failure
  publication-title: Cell Host Microbe
– volume: 8
  start-page: 780
  year: 2017
  article-title: Antiviral functions of human immunodeficiency virus type 1 (HIV‐1)‐specific IgG antibodies: effects of antiretroviral therapy and implications for therapeutic HIV‐1 vaccine design
  publication-title: Front. Immunol.
– volume: 355
  start-page: 395
  year: 2017
  end-page: 8
  article-title: IgG antibodies to dengue enhanced for FcγRIIIA binding determine disease severity
  publication-title: Science
– volume: 19
  year: 2020
  article-title: Compromised steady‐state germinal center activity with age in nonhuman primates
  publication-title: Aging Cell
– year: 2020
  article-title: Antibody responses to SARS‐CoV‐2 in patients of novel coronavirus disease 2019
  publication-title: Clin. Infect. Dis.
– volume: 39
  start-page: 529
  year: 2017
  end-page: 39.13
  article-title: Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology
  publication-title: Semin. Immunopathol.
– volume: 333
  start-page: 65
  year: 2018
  end-page: 79
  article-title: Immunoglobulin G glycosylation in aging and diseases
  publication-title: Cell. Immunol.
– year: 2020
  article-title: Profiling early humoral response to diagnose novel coronavirus disease (COVID‐19)
  publication-title: Clin. Infect. Dis.
– volume: 4
  year: 2019
  article-title: Anti‐spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS‐CoV infection
  publication-title: JCI Insight.
– volume: 85
  start-page: 10582
  year: 2011
  end-page: 97
  article-title: Anti‐severe acute respiratory syndrome coronavirus spike antibodies trigger infection of human immune cells via a pH‐ and cysteine protease‐independent FcγR pathway
  publication-title: J. Virol.
– year: 2020
  article-title: Neutralizing antibody responses to SARS‐CoV‐2 in a COVID‐19 recovered patient cohort and their implications
  publication-title: medRxiv
– volume: 451
  start-page: 208
  year: 2014
  end-page: 14
  article-title: Antibody‐dependent SARS coronavirus infection is mediated by antibodies against spike proteins
  publication-title: Biochem. Biophys. Res. Commun.
– year: 2020
  article-title: Profile of IgG and IgM antibodies against severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
  publication-title: Clin. Infect. Dis.
– volume: 20
  start-page: 565
  year: 2020
  end-page: 74
  article-title: Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS‐CoV‐2: an observational cohort study
  publication-title: Lancet Infect. Dis.
– volume: 7
  year: 2012
  article-title: Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus
  publication-title: PLoS One
– ident: e_1_2_2_18_1
  doi: 10.1016/j.cellimm.2018.07.009
– ident: e_1_2_2_14_1
  doi: 10.1016/j.bbrc.2014.07.090
– ident: e_1_2_2_13_1
  doi: 10.1021/acsinfecdis.6b00006
– ident: e_1_2_2_17_1
  doi: 10.1111/acel.13087
– ident: e_1_2_2_3_1
  doi: 10.3389/fimmu.2017.00780
– ident: e_1_2_2_11_1
  doi: 10.1007/s00281-017-0629-x
– ident: e_1_2_2_15_1
  doi: 10.1371/journal.pntd.0002274
– ident: e_1_2_2_7_1
  doi: 10.1038/s41586-020-2196-x
– ident: e_1_2_2_19_1
  doi: 10.1101/2020.03.30.20047365
– ident: e_1_2_2_12_1
  doi: 10.1371/journal.pone.0035421
– ident: e_1_2_2_8_1
  doi: 10.1093/cid/ciaa489
– ident: e_1_2_2_9_1
  doi: 10.1128/JVI.00671-11
– ident: e_1_2_2_10_1
  doi: 10.1172/jci.insight.123158
– ident: e_1_2_2_16_1
  doi: 10.1126/science.aai8128
– ident: e_1_2_2_6_1
  doi: 10.1016/S1473-3099(20)30196-1
– ident: e_1_2_2_5_1
  doi: 10.1093/cid/ciaa34
– ident: e_1_2_2_4_1
  doi: 10.1093/cid/ciaa310
– ident: e_1_2_2_2_1
  doi: 10.1016/j.chom.2020.04.009
SSID ssj0003505
Score 2.4314394
SourceID pubmedcentral
proquest
crossref
pubmed
wiley
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 680
SubjectTerms antibodies
Antibody Formation
Betacoronavirus
Commentaries
Coronavirus
Coronavirus Infections
COVID-19
Humans
immunopathology
Pandemics
Pneumonia, Viral
Respiratory diseases
SARS Virus
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Title The role of SARS‐CoV‐2 antibodies in COVID‐19: Healing in most, harm at times
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fresp.13852
https://www.ncbi.nlm.nih.gov/pubmed/32436320
https://www.proquest.com/docview/2414179930
https://search.proquest.com/docview/2405331124
https://pubmed.ncbi.nlm.nih.gov/PMC7280731
Volume 25
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NTtwwEB4hDlUvQH8oAVq5ak-IrDZ27CRVL6vdIlqJtmIL4oIi20nECpEgNnvhxCPwjH2SzjjJwhYJCS5RYk8SxzNjfxOPZwA-mwzVLFPWj1Xf-qHKYl9nofRVWBgb8CxqUicc_FT7R-GPE3myBF-7vTBNfIj5DzfSDDdek4JrM72n5GiNXvYCEUsagAMRkT_X6PAudpSQzn8RrS2BEDJJ2tik5MZzd-vibPQAYj70lLyPYN0UtLcKp13jG8-T896sNj17_V9cx-d-3RqstNiUDRphegVLefkaXhy0q-9vYIwyxcgdkVUFGw8Ox39vbofVMR45QwZNTEUuiWxSsuGv4-8jLA-SL4w2OuH8SMUX1bTeZRQsm-maubT2b-Fo79uf4b7fJmXwLWIr7hciigqVJVpaabNCqJjrgsfGqDC2XGibI4jKpbRCKsQ2FukTE4V5ECsbSbxch-WyKvMNYIKj_CC4t5nph4E1SV8bzgMjtcUHSu7Bp4456WUTeyPtbBbqn9T1jwfbHd_SVv-mKeISSq2WiL4HH-fVqDm0HKLLvJoRDe1DRrwZevCuYfP8NQgzhRIc744WBGBOQFG5F2vKyZmLzk35viIReLDj-PtIy1PUsd_ubPMpxFvwkpPR73yGt2G5vprl7xEZ1eaD04B_p5ILaA
link.rule.ids 230,315,783,787,888,1378,27936,27937,46306,46730
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1dT9swFL2aQNr2AhtsEMY2I_Y0LVVjx06yN9QOlY-yiQLiLYqdRFSIpKLpC0_8hP3G_ZLd66QtBQlpe4mS2Pny9bGPnetzAb7oFGGWKuOGqm1cX6Whm6S-dJWfa-PxNKhDJ_RPVO_cP7yUl41vDq2FqfUhZhNuhAzbXhPAaUL6AcpxODpqeSKU2AIvI94FRW7ons7Vo4S0How43hJIIqOoUSclR575tYv90ROS-dRX8iGHtZ3Q_modaXVstQvJ9-S6Nal0y9w9Unb87-97AysNPWV7dX16Cy-yYg1e9psf8OswwGrFyCORlTkb7J0O_tz_7pQXuOUMbTTUJXklsmHBOj8vDrp43ou-M1rrhF0knb4px9U3RnrZLKmYjWz_Ds73f5x1em4Tl8E1SK-4m4sgyFUaJdJIk-ZChTzJeai18kPDRWIy5FGZlEZIhfTGYP5IB37mhcoEEg_fw1JRFtkmMMGxCiG_N6lu-57RUTvRnHtaJgZvKLkDu1PrxKNafiOeDluofGJbPg5sTw0XNxAcx0hNKLpaJNoO7MySETz0RyQpsnJCeWgpMlJO34GN2s6zxyDTFEpwvDpYqAGzDCTMvZhSDK-sQDeF_AqE58BXa-Bn3jxGmP2ye1v_kvkzvOqd9Y_j44OTow_wmtMcgHUh3oal6naSfUSiVOlPFg5_ATvcD4A
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5VRaq48H6kFDCCEyKrjV9JEJdqy6oFWqourXpBUWwnYlU1WbXZC6f-hP5GfgkzTrLtUgkJLlFijxPHM2N_tsczAG-MQzVz2oaJHtpQapeEuZMq1LI0NuIubkMn7O7p7UP56Vgdr8CH_ixM6x9iseBGmuH7a1LwmSuvKTnORmeDSCQKO-BbUiP0JUh0cOU8SihvwIjTLYEYMk0756Rkx3NVdnk4uoExb5pKXoewfgwa34Xvfe1b05OTwbwxA_vzD8eO__t79-BOB07ZZitN92GlqB7A2m63_f4QJihUjOwRWV2yyebB5NfF5ag-witnyKGpqckmkU0rNvp6tLOF6VH6ntFJJxwgKfm0Pm_eMfKWzfKG-bj2j-Bw_PHbaDvsojKEFsEVD0sRx6V2aa6ssq4UOuF5yRNjtEwsF7ktEEUVSlmhNIIbi_SpiWURJdrGCh8fw2pVV8VTYIKjACG6t84MZWRNOswN55FRucUXKh7A65452ax1vpH1kxZqn8y3TwAbPd-yTgHPMwQmFFstFcMAXi2yUXVoPySvinpONHQQGQGnDOBJy-bFZxBnCi04lo6XBGBBQG65l3Oq6Q_vnpsCfsUiCuCt5-9fap6hku37u_V_IX4Ja_tb4-zLzt7nZ3Cb0wKAtx_egNXmbF48R5TUmBdeGX4DDTQOLw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+role+of+SARS-CoV-2+antibodies+in+COVID-19%3A+Healing+in+most%2C+harm+at+times&rft.jtitle=Respirology+%28Carlton%2C+Vic.%29&rft.au=French%2C+Martyn+A&rft.au=Moodley%2C+Yuben&rft.date=2020-07-01&rft.eissn=1440-1843&rft.volume=25&rft.issue=7&rft.spage=680&rft_id=info:doi/10.1111%2Fresp.13852&rft_id=info%3Apmid%2F32436320&rft.externalDocID=32436320
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1323-7799&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1323-7799&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1323-7799&client=summon